Cancer associated fibroblasts (CAFs) in tumor microenvironment.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Frontiers in Bioscience

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/3613PMID 20036813PMCID PMC2905156
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Tumorigenesis and Neoplastic Progression Stromal Fibroblasts in Colorectal Liver Metastases Originate From Resident Fibroblasts and Generate an Inflammatory Microenvironment

  2010cited by this paper
• Minireview: regulation of prostatic stem cells by stromal niche in health and disease.

  2008cited by this paper
• Pancreatic cancer associated fibroblasts display normal allelotypes

  2008cited by this paper
• The role of endothelial-to-mesenchymal transition in cancer progression

  2008cited by this paper
• Fibroblast independency in tumors: implications in cancer therapy.

  2008cited by this paper
• Fibroblasts as novel therapeutic targets in chronic inflammation

  2008cited by this paper
• Characterization of Adult Prostatic Progenitor/Stem Cells Exhibiting Self‐Renewal and Multilineage Differentiation

  2008cited by this paper
• Translational Medicine: The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine

  2008cited by this paper
• Stem cells and niches: mechanisms that promote stem cell maintenance throughout life.

  2008cited by this paper
• Stromal myofibroblasts are drivers of invasive cancer growth

  2008cited by this paper
• Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells.

  2008cited by this paper
• Molecular and cellular regulators of cancer angiogenesis.

  2007cited by this paper
• Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells

  2007cited by this paper
• Expression and function of α-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation

  2007cited by this paper
• Tumor microenvironment: The role of the tumor stroma in cancer

  2007cited by this paper
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• Location, location, location: the cancer stem cell niche.

  2007cited by this paper
• Prostate cancer stem/progenitor cells: Identification, characterization, and implications

  2007cited by this paper
• Genomic instability within tumor stroma and clinicopathological characteristics of sporadic primary invasive breast carcinoma.

  2007cited by this paper
• A perivascular niche for brain tumor stem cells.

  2007cited by this paper
• Immune surveillance of tumors.

  2007cited by this paper
• Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts.

  2007cited by this paper
• Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

  2007cited by this paper
• Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

  2006cited by this paper
• The bone marrow functionally contributes to liver fibrosis.

  2006cited by this paper
• Suppression of human brain tumor with interference RNA specific for tenascin-C

  2006cited by this paper
• Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

  2006cited by this paper
• Relevance of the stroma and epithelial-mesenchymal transition (EMT) for the rheumatic diseases

  2006cited by this paper
• TGFbeta1 induces epithelial-mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture.

  2006cited by this paper
• Bone marrow and tumour stroma: an intimate relationship

  2006cited by this paper
• Connective tissue growth factor–specific antibody attenuates tumor growth, metastasis, and angiogenesis in an orthotopic mouse model of pancreatic cancer

  2006cited by this paper
• TGFβ1 induces epithelial–mesenchymal transition, but not myofibroblast transdifferentiation of human kidney tubular epithelial cells in primary culture

  2006cited by this paper
• Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells

  2006cited by this paper
• A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel/platinum containing chemotherapy: a National Cancer Institute of Canada Clinical Trials Group Study.

  2006cited by this paper
• Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake.

  2006cited by this paper
• Salvage radioimmunotherapy with murine iodine-131-labeled antitenascin monoclonal antibody 81C6 for patients with recurrent primary and metastatic malignant brain tumors: phase II study results.

  2006cited by this paper
• A crosstalk between the Wnt and the adhesion-dependent signaling pathways governs the chemosensitivity of acute myeloid leukemia

  2006cited by this paper
• Epithelial cells and their neighbors I. Role of intestinal myofibroblasts in development, repair, and cancer.

  2005cited by this paper
• Pre-clinical Study of 213Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer

  2005cited by this paper
• In vivo imaging of specialized bone marrow endothelial microdomains for tumour engraftment

  2005cited by this paper
• Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis

  2005cited by this paper
• Selective evolution of stromal mesenchyme with p53 loss in response to epithelial tumorigenesis.

  2005cited by this paper
• Suppression of Tumor Development and Metastasis Formation in Mice Lacking the S 100 A 4 ( mts 1 )

  2005cited by this paper
• Supplemental Data Stromal Fibroblasts Present in Invasive Human Breast Carcinomas Promote Tumor Growth and Angiogenesis through Elevated SDF-1/CXCL12 Secretion

  2005cited by this paper
• Interleukin‐4 downregulates TNFα‐induced IL‐8 production in keratinocytes

  2005cited by this paper
• Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis.

  2005cited by this paper
• Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.

  2005cited by this paper
• Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth

  2005cited by this paper
• Interleukin-4 downregulates TNFalpha-induced IL-8 production in keratinocytes.

  2005cited by this paper
• Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.

  2005cited by this paper
• Coevolution of cancer and stromal cellular responses.

  2005cited by this paper
• Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors

  2005cited by this paper
• Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.

  2005cited by this paper
• PT-100, a Small Molecule Dipeptidyl Peptidase Inhibitor, Has Potent Antitumor Effects and Augments Antibody-Mediated Cytotoxicity via a Novel Immune Mechanism

  2004cited by this paper
• Identification of human brain tumour initiating cells

  2004cited by this paper
• Reconstruction of functionally normal and malignant human breast tissues in mice.

  2004cited by this paper
• Bone Marrow Contribution to Tumor-Associated Myofibroblasts and Fibroblasts

  2004cited by this paper
• Heterogeneity of myofibroblast phenotypic features: an example of fibroblastic cell plasticity

  2004cited by this paper
• Tenascin‐C and SF/HGF produced by myofibroblasts in vitro provide convergent proinvasive signals to human colon cancer cells through RhoA and Rac

  2004cited by this paper
• Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles

  2004cited by this paper
• A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients

  2004cited by this paper
• Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

  2004cited by this paper
• Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

  2004cited by this paper
• Molecular characterization of the tumor microenvironment in breast cancer.

  2004cited by this paper
• A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

  2003cited by this paper
• Generation of a FasL-based Proapoptotic Fusion Protein Devoid of Systemic Toxicity due to Cell-surface Antigen-restricted Activation*

  2003cited by this paper
• Function and regulation of melanoma–stromal fibroblast interactions: when seeds meet soil

  2003cited by this paper
• A phase I study of anti-kinase insert domain-containing receptor antibody, IMC-1C11, in patients with liver metastases from colorectal carcinoma.

  2003cited by this paper
• Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes.

  2003cited by this paper
• Epithelial to mesenchymal transition in human breast cancer can provide a nonmalignant stroma.

  2003cited by this paper
• TGF-beta in mammary gland development and breast cancer.

  2003cited by this paper
• Global gene expression profiles in fibroblasts from synovial, skin and lymphoid tissue reveals distinct cytokine and chemokine expression patterns

  2003cited by this paper
• Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects

  2003cited by this paper
• A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

  2003cited by this paper
• TGF-β in Mammary Gland Development and Breast Cancer

  2003cited by this paper
• Smooth muscle cell differentiation in mammary stromo‐epithelial lesions with evidence of a dual origin: stromal myofibroblasts and myoepithelial cells

  2003cited by this paper
• Role of tissue stroma in cancer cell invasion

  2003cited by this paper
• Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

  2002cited by this paper
• Tumor-Associated Macrophages in Breast Cancer

  2002cited by this paper
• Evidence that fibroblasts derive from epithelium during tissue fibrosis.

  2002cited by this paper
• MMP-2 and MMP-9 Expression in Breast Cancer-Derived Human Fibroblasts is Differentially Regulated by Stromal-Epithelial Interactions

  2002cited by this paper
• Marimastat as maintenance therapy for patients with advanced gastric cancer: a randomised trial

  2002cited by this paper
• Role of stroma in carcinogenesis of the prostate.

  2002cited by this paper
• In vivo glioma growth requires host-derived matrix metalloproteinase 2 for maintenance of angioarchitecture.

  2002cited by this paper
• PTEN Protects p53 from Mdm2 and Sensitizes Cancer Cells to Chemotherapy*

  2002cited by this paper
• Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.

  2002cited by this paper
• Epithelial–mesenchymal transitions in tumour progression

  2002cited by this paper
• Myofibroblasts and mechano-regulation of connective tissue remodelling

  2002cited by this paper
• Metastasis is driven by sequential elevation of H-ras and Smad2 levels

  2002cited by this paper
• Diversity, topographic differentiation, and positional memory in human fibroblasts

  2002cited by this paper
• Lymphostromal interactions in thymic development and function

  2001cited by this paper
• The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.

  2001cited by this paper
• The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion

  2001cited by this paper
• Inflammation and cancer: back to Virchow?

  2001cited by this paper
• Construction of a bispecific single chain antibody for recruitment of cytotoxic T cells to the tumour stroma associated antigen fibroblast activation protein.

  2001cited by this paper
• Stromal cells can contribute oncogenic signals.

  2001cited by this paper
• How matrix metalloproteinases regulate cell behavior.

  2001cited by this paper
• Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors.

  2001cited by this paper
• Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation.

  2001cited by this paper

• Targeting cancer stem cells as the most aggressive and tumor-initiating cells

  2026cites this paper
• Radiolabelled FAPI Radiotracers in Oncology: A Comprehensive Review of Current Diagnostic and Emerging Therapeutic Applications

  2026cites this paper
• Decoding inflammatory regulation in ovarian cancer at single-cell resolution

  2026cites this paper
• POSTN+ fibroblast-secreted small extracellular vesicles drive macrophage M2 polarization through BMP4/BMPR2/Smad signaling

  2026cites this paper
• Stromal cells contribute to progression, recurrence, and metastasis in oral squamous cell carcinoma: a call for therapy.

  2026cites this paper
• Targeting the Tumor Microenvironment in Triple-Negative Breast Cancer: Emerging Roles of Monoclonal Antibodies and Immune Modulation

  2026cites this paper
• Photobiomodulation mitigates the inhibitory effects of pirfenidone on cancer-associated fibroblasts and their pro-tumorigenic properties: a cause for concern

  2026cites this paper
• A Patient-Derived Scaffold-Based 3D Culture Platform for Head and Neck Cancer: Preserving Tumor Heterogeneity for Personalized Drug Testing

  2025cites this paper
• Nanomedicine-Mediated Therapies to Target Cancer Stem Cells: An Emerging Technology.

  2025cites this paper
• Direct cell interactions potentially regulate transcriptional programmes that control the responses of high grade serous ovarian cancer patients to therapy

  2025cites this paper
• TBX3 shapes an immunosuppressive microenvironment and induces immunotherapy resistance

  2025cites this paper
• A comprehensive pan-cancer analysis of RNF187 in human tumors

  2025cites this paper
• Metabolic crossroads: unravelling immune cell dynamics in gastrointestinal cancer drug resistance

  2025cites this paper
• Development of Cysteic Acid-Modified FAP Radioligands for Enhanced Renal Clearance: From Preclinical Optimization to First-in-Human Study.

  2025cites this paper
• Categorizing high-grade serous ovarian carcinoma into clinically relevant subgroups using deep learning–based histomic clusters

  2025cites this paper
• Mendelian Randomization Analysis of Mitochondria‐Related Genes and Screening of Prognostic Genes in Colorectal Cancer

  2025cites this paper
• An early-stage 3D fibroblast-featured tumor model mimics the gene expression of the naïve tumor microenvironment, including genes involved in cancer progression and drug resistance

  2025cites this paper
• Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts.

  2025cites this paper
• Integrated single-cell and bulk RNA sequencing analysis establishes a cancer associated fibroblast-related signature for predicting prognosis and therapeutic responses in neuroblastoma

  2025cites this paper
• Triple co-culture spheroid models of lung and ovarian carcinoma cell lines for the in vitro testing of antitumor liposomes

  2025cites this paper
• Single-cell RNA sequencing reveals a fibroblast gene signature that promotes T-cell infiltration in muscle-invasive bladder cancer

  2025cites this paper
• Exposure to Brominated Flame Retardants During Pregnancy and Lactation Increases the Prevalence of Breast Lesions and Cancer-Associated Pathways in Sprague-Dawley Rats.

  2025cites this paper
• Cancer-associated fibroblast-derived exosomes in cancer progression: a focus on hepatocellular carcinoma.

  2025cites this paper
• Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancer.

  2025cites this paper
• CAF-derived exosomes: orchestrators of dysregulated signaling pathways in breast cancer progression

  2025cites this paper
• Tumor-associated endothelial cells in tumor immune escape and immunotherapy: multifaceted roles and treatment approaches

  2025cites this paper
• Myofibroblastic CAFs arising from bone-resident osteoblast precursors retain an osteolineage signature and support breast cancer progression via Osterix-mediated signaling

  2025cites this paper
• Decoding the Tumor Microenvironment: Insights and New Targets from Single-Cell Sequencing and Spatial Transcriptomics

  2025cites this paper
• Clinical study on bile excretion pattern of [18F]AlF-FAPI-74 and measures to eliminate its physiological uptake in the hepatobiliary system

  2025cites this paper
• pH of Microenvironment Directly Modulates the Phenotype and Function of Cancer-Associated Fibroblasts

  2025cites this paper
• Role of nanomedicines in lung cancer treatment and diagnosis: opportunities and challenges

  2025cites this paper
• Herbal Nanotherapeutics: A Targeted Approach to Modulating the Tumor Microenvironment for Enhanced Antitumor Efficacy

  2025cites this paper
• Thermosensitive Hydrogel Loaded with α-Mangostin for Enhanced Antitumor Effect of Doxorubicin.

  2025cites this paper
• Tumor Microenvironment On‐A‐Chip and Single‐Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression

  2025cites this paper
• Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer

  2025cites this paper
• Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment

  2025cites this paper
• Exosomal miRNA-188-3p derived from cancer-associated fibroblasts promotes ferroptosis in cervical cancer: Medical Biothermal Image Analysis.

  2025cites this paper
• Targeting the adenosinergic axis in cancer immunotherapy: Insights into A2A and A2B receptors and novel clinical combination strategies.

  2025cites this paper
• Inhibition of ACVR1 in Cancer-Associated Fibroblasts Suppresses Colorectal Cancer Cell Growth

  2025cites this paper
• Bridging cell morphological behaviors and molecular dynamics in multi-modal spatial omics with MorphLink

  2025cites this paper
• Fibroblast activation protein and the tumour microenvironment: challenges and therapeutic opportunities

  2025cites this paper
• Targeting CAF-specific metabolic pathways in breast cancer

  2025cites this paper
• Exploring Morphology of Thermoplasmonic Nanoparticles to Synergize Immunotherapeutic Fibroblast Activation Protein‐Positive Cell Sensitization and Photothermal Therapy

  2025cites this paper
• pH-sensitive hyaluronic acid nanomicelles for co-delivery of capsaicin and doxorubicin enhance the treatment of anaplastic thyroid carcinoma.

  2025cites this paper
• The clinical significance and potential therapeutic target of tumor-associated macrophage in non-small cell lung cancer

  2025cites this paper
• Boosting antitumor immunity in breast cancers: Potential of adjuvants, drugs, and nanocarriers

  2024cites this paper
• Agent-based modeling for the tumor microenvironment (TME).

  2024cites this paper
• Histologic Reaction Patterns of Lymph Node Involvement in Ovarian Serous Borderline Tumors.

  2024cites this paper
• Generation of Murine Cancer Cell Lines

  2024cites this paper
• Novel immunotherapeutic approaches in gastric cancer

  2024cites this paper
• Rational modifications on N-(4-quinolinoyl)-Gly-2-cyanopyrrolidine to develop fibroblast activation protein-targeted radioligands with improved affinity and tumor uptake.

  2024cites this paper
• Exosomal signaling in gynecologic cancer development: The role of cancer-associated fibroblasts.

  2024cites this paper
• 99mTc-FAPI-04 SPECT/CT outperforms contrast-enhanced CT in detecting metastasis in postoperative patients with colorectal cancer

  2024cites this paper
• KRT14 as a potential prognostic marker for metastasis in metaplastic breast carcinoma

  2024cites this paper
• Particular exosomal micro-RNAs and gastrointestinal (GI) cancer cells' roles: Current theories.

  2024cites this paper
• Sequentially Released Liposomes Enhance Anti-Liver Cancer Efficacy of Tetrandrine and Celastrol-Loaded Coix Seed Oil

  2024cites this paper
• Interactions between cancer and stroma mediated by extracellular vesicles

  2024cites this paper
• Mesenchymal stromal cells as cancer promoters

  2024cites this paper
• Exploration of oxidized phosphocholine profile in non-small-cell lung cancer

  2024cites this paper
• Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts

  2024cites this paper
• PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance

  2024cites this paper
• A Genuinely Hybrid, Multiscale 3D Cancer Invasion and Metastasis Modelling Framework

  2024cites this paper
• Investigation of tumour environments through advancements in microtechnology and nanotechnology.

  2024cites this paper
• The Multifaced Role of Collagen in Cancer Development and Progression

  2024cites this paper
• Intercellular transfer of multidrug resistance mediated by extracellular vesicles

  2024cites this paper
• Cancer Spheroids Embedded in Tissue-Engineered Skin Substitutes: A New Method to Study Tumorigenicity In Vivo

  2024cites this paper
• Substrate stiffness-dependent activation of Hippo pathway in cancer associated fibroblasts.

  2024cites this paper
• Crosstalk between CAFs and tumour cells in head and neck cancer

  2024cites this paper
• The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities

  2024influential citation
• Molecular Prospective on Malignant Transformation of Mesenchymal Stem Cells: An Issue in Cell Therapy

  2024cites this paper
• Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma

  2024cites this paper
• Oral Papillary Squamous Cell Carcinoma and Oral Squamous Cell Carcinoma: A Histopathological and Immunohistochemical Comparative Study

  2024cites this paper
• Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases

  2024cites this paper
• Tumor microenvironment: A playground for cells from multiple diverse origins.

  2024cites this paper
• Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study

  2024cites this paper
• Senescent CAFs mediate immunosuppression and drive breast cancer progression.

  2024cites this paper
• Differential roles of normal and lung cancer-associated fibroblasts in microvascular network formation

  2024cites this paper
• Comparative transcriptome of normal and cancer-associated fibroblasts

  2024cites this paper
• Targeting anticancer immunity in melanoma tumour microenvironment: unleashing the potential of adjuvants, drugs, and phytochemicals

  2024cites this paper
• The Tumor Stroma of Squamous Cell Carcinoma: A Complex Environment That Fuels Cancer Progression

  2024cites this paper
• Evaluation of the significance of tumor stromal patterns and peri-tumoral inflammation in head and neck squamous cell carcinoma with special reference to the Yamamoto-Kohama classification.

  2024cites this paper
• Beyond Small Molecules: Antibodies and Peptides for Fibroblast Activation Protein Targeting Radiopharmaceuticals

  2024cites this paper
• Stable and oscillatory hypoxia differentially regulate invasibility of breast cancer associated fibroblasts

  2024cites this paper
• The role of the microenvironment in tumor growth and spreading

  2024cites this paper
• Stable and Oscillatory Hypoxia Differentially Regulate Invasibility of Breast Cancer Associated Fibroblasts

  2024cites this paper
• Cancer-associated fibroblasts secrete FGF5 to inhibit ferroptosis to decrease cisplatin sensitivity in nasopharyngeal carcinoma through binding to FGFR2

  2024cites this paper
• Non-coding RNA in the Regulation of Gastric Cancer Tumorigenesis: Focus on microRNAs and Exosomal microRNAs

  2024cites this paper
• PDPN/CCL2/STAT3 feedback loop alter CAF heterogeneity to promote angiogenesis in colorectal cancer

  2024cites this paper
• Unveiling the potential effects of resveratrol in lung cancer treatment: Mechanisms and nanoparticle-based drug delivery strategies.

  2024cites this paper
• AR loss in prostate cancer stroma mediated by NF-κB and p38-MAPK signaling disrupts stromal morphogen production

  2024cites this paper
• Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures

  2024cites this paper
• Exploring Tumor-Promoting Qualities of Cancer-Associated Fibroblasts and Innovative Drug Discovery Strategies With Emphasis on Thymoquinone

  2024cites this paper
• Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer

  2024influential citation
• Responsive biomaterials: optimizing control of cancer immunotherapy

  2023cites this paper
• Cancer-Associated Fibroblasts Together with a Decline in CD8+ T Cells Predict a Worse Prognosis for Breast Cancer Patients

  2023cites this paper
• Microsphere-Enabled Modular Formation of Miniaturized In Vitro Breast Cancer Models.

  2023cites this paper
• Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer

  2023cites this paper
• Navigating Tumour Microenvironment and Wnt Signalling Crosstalk: Implications for Advanced Cancer Therapeutics

  2023cites this paper
• The power of phages: revolutionizing cancer treatment

  2023cites this paper
• Synergetic impact of combined navoximod with cisplatin mitigates chemo-immune resistance via blockading IDO1+ CAFs-secreted Kyn/AhR/IL-6 and pol ζ-prevented CIN in human oral squamous cell carcinoma.

  2023cites this paper